A previous study treated T2DM patients with RSG for 26 weeks and showed that RSG significantly reduces C-reactive protein expression, which is positively correlated with IL-6 expression, suggesting that it may affect inflammatory pathways through the transcriptional mechanism [11, 12]. This evidence concerns the gene CRP and type 2 diabetes mellitus.